MCA
SNY icon

Maryland Capital Advisors’s Sanofi SNY Stock Holding History

Maryland Capital Advisors’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-75
Closed -$3.65K – 252
2024
Q1 		$3.65K Sell
75
-75
-50% -$3.66K ﹤0.01% 190
2023
Q4 		$7.46K Hold
150
– – ﹤0.01% 178
2023
Q3 		$8.05K Hold
150
– – 0.01% 176
2023
Q2 		$8.09K Hold
150
– – 0.01% 181
2023
Q1 		$8.16K Hold
150
– – 0.01% 184
2022
Q4 		$7.26K Hold
150
– – 0.01% 187
2022
Q3 		$6K Hold
150
– – 0.01% 191
2022
Q2 		$8K Buy
+150
New +$7.96K 0.01% 182

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Maryland Capital Advisors's SNY Position: Q2 2024 in Review

Maryland Capital Advisors sold out of Sanofi (SNY) in Q2 2024, closing a stake of 75 shares — an estimated $3.65K sold.

Maryland Capital Advisors first reported a position in SNY in Q2 2022 and held it in 8 quarters. The position peaked at $8.16K in Q1 2023. 730 funds tracked by Wall St. Rank hold SNY as of Q2 2024.

  • Maryland Capital Advisors reported no remaining Sanofi position as of Q2 2024 after selling out during the quarter.
  • Maryland Capital Advisors sold 75 Sanofi shares in Q2 2024, an estimated $3.65K.
  • Maryland Capital Advisors first reported a position in Sanofi in Q2 2022 and held it in 8 quarters.
  • Maryland Capital Advisors's Sanofi position peaked at $8.16K in Q1 2023.
  • 730 funds tracked by Wall St. Rank held Sanofi as of Q2 2024.

Based on Maryland Capital Advisors's 13F filing for Q2 2024, filed 25 Jul 2024.